Breast cancer
Conditions
Interventions
case series:None
Sponsors
Shandong Cancer Hospital and Institute
Eligibility
Sex/Gender
Female
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Aged at least 18 years; 2. ECOG score: 0-3; 3. Expected survival of more than 3 months; 4. Subjects with unresectable or recurrent/metastatic HER-2 positive breast cancer confirmed by histology or pathology (no limit on the number of treatment lines); 5. The subjects voluntarily joined the study, signed the informed consent, had good compliance, and cooperated with follow-up.
Exclusion criteria
Exclusion criteria: 1. Previous or concurrent malignant tumors; 2. Those who have a history of psychotropic drug abuse and cannot abstain or have mental disorders; 3. Pregnant and lactating patients; 4. Patients allergic to Initumab; 5. Other patients who were not eligible for inclusion as judged by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Progression Free Survival;Adverse Events;Overall Survival;Objective Response Rate;Duration of Response;Clinical Benefit Rate;Quality of Life;Compliance; | — |
Countries
China
Contacts
Public ContactLi Huihui
Shandong Cancer Hospital and Institute
Outcome results
None listed